Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Minotti

Showing results (71-80 of 130) with videos related to

Pageof 13
Sort By:
Molecular Interventions|May 5, 2011
Matters of the heart: the case of TNFalpha-targeting drugsFabio Cacciapaglia, Pierantonio Menna, Luca Navarini, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 25, 2022
Cardiac Anthracycline Accumulation and B-Type Natriuretic Peptide to Define Risk and Predictors of Cancer Treatment-Related Early Diastolic DysfunctionGiorgio Minotti, Emanuela Salvatorelli, Giorgio Reggiardo, et al.
JACC. Cardiooncology|October 31, 2024
Anthracycline Cardiotoxicity in Adult Cancer Patients: <i>JACC: CardioOncology</i> State-of-the-Art ReviewMassimiliano Camilli, Carlo Maria Cipolla, Susan Dent, et al.
Seminars in Oncology|November 22, 2019
Mechanisms and clinical course of cardiovascular toxicity of cancer treatment II. Hematology<sup>☆</sup>Massimo Breccia, Joseph R Carver, Sebastian Szmit, et al.
Biochemical Pharmacology|September 10, 2003
Anthracycline secondary alcohol metabolite formation in human or rabbit heart: biochemical aspects and pharmacologic implicationsAlvaro Mordente, Giorgio Minotti, Giuseppe Ettore Martorana, et al.
Expert Opinion on Drug Safety|June 4, 2011
Anthracycline cardiotoxicityPierantonio Menna, Odalys Gonzalez Paz, Massimo Chello, et al.
Seminars in Oncology|December 1, 2019
Cardio-oncological management of patientsDaniela M Cardinale, Ana Barac, Adam Torbicki, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 15, 2006
Paclitaxel and docetaxel stimulation of doxorubicinol formation in the human heart: implications for cardiotoxicity of doxorubicin-taxane chemotherapiesEmanuela Salvatorelli, Pierantonio Menna, Sabrina Cascegna, et al.
Seminars in Oncology|November 27, 2019
Cardio-oncology in clinical studies and real lifeSusan F Dent, Thomas M Suter, Teresa López-Fernández, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2008
Anthracycline cardiotoxicity: from bench to bedsideLuca Gianni, Eugene H Herman, Steven E Lipshultz, et al.
Pageof 13

Showing results (71-80 of 130) with videos related to

Sort By:
Pageof 13
Molecular Interventions|May 5, 2011
Matters of the heart: the case of TNFalpha-targeting drugsFabio Cacciapaglia, Pierantonio Menna, Luca Navarini, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 25, 2022
Cardiac Anthracycline Accumulation and B-Type Natriuretic Peptide to Define Risk and Predictors of Cancer Treatment-Related Early Diastolic DysfunctionGiorgio Minotti, Emanuela Salvatorelli, Giorgio Reggiardo, et al.
JACC. Cardiooncology|October 31, 2024
Anthracycline Cardiotoxicity in Adult Cancer Patients: <i>JACC: CardioOncology</i> State-of-the-Art ReviewMassimiliano Camilli, Carlo Maria Cipolla, Susan Dent, et al.
Seminars in Oncology|November 22, 2019
Mechanisms and clinical course of cardiovascular toxicity of cancer treatment II. Hematology<sup>☆</sup>Massimo Breccia, Joseph R Carver, Sebastian Szmit, et al.
Biochemical Pharmacology|September 10, 2003
Anthracycline secondary alcohol metabolite formation in human or rabbit heart: biochemical aspects and pharmacologic implicationsAlvaro Mordente, Giorgio Minotti, Giuseppe Ettore Martorana, et al.
Expert Opinion on Drug Safety|June 4, 2011
Anthracycline cardiotoxicityPierantonio Menna, Odalys Gonzalez Paz, Massimo Chello, et al.
Seminars in Oncology|December 1, 2019
Cardio-oncological management of patientsDaniela M Cardinale, Ana Barac, Adam Torbicki, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 15, 2006
Paclitaxel and docetaxel stimulation of doxorubicinol formation in the human heart: implications for cardiotoxicity of doxorubicin-taxane chemotherapiesEmanuela Salvatorelli, Pierantonio Menna, Sabrina Cascegna, et al.
Seminars in Oncology|November 27, 2019
Cardio-oncology in clinical studies and real lifeSusan F Dent, Thomas M Suter, Teresa López-Fernández, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2008
Anthracycline cardiotoxicity: from bench to bedsideLuca Gianni, Eugene H Herman, Steven E Lipshultz, et al.
Pageof 13